| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8411109 | Drug Discovery Today: Disease Models | 2011 | 7 Pages |
Abstract
Tumor-stroma interactions at the site of primary tumor contribute to increasing tumorogenesis, invasiveness, epithelial-mesenchymal transition (EMT), angiogenesis, and metastasis. Similarly, the tumor-stroma interaction at the target metastatic site greatly contributes to increasing cancer cell survival, homing, and colonization. This review aims to summarize the evidence that unveils crucial pathways involved at the tumor-stromal interphase. Using bone as metastatic niche for the dissemination of primary tumors, it also provides an update regarding the relevance of key molecular targets and the development of rational anti-metastatic therapeutic strategies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Fernando Lecanda,